Get started
Author

S. Oesterreich

31P ERBB2 Mutations in Metastatic Breast Cancer: Histology-Specific Molecular, Immune, and Clonal Features
2026 · G. Nader Marta, S.K. Deshmukh, et al. · ESMO Open
PDF
89P Longitudinal genomic profiling of circulating tumor DNA in metastatic invasive lobular (ILC) and no special type (NST) breast cancer
2026 · J. Foldi, D. Liu, et al. · ESMO Open
Abstract PD9-07: The Genomic, Transcriptomic, and Immune Hallmarks of Metastatic Lobular Breast Cancer
2026 · G. Nader-Marta, S. Kumar Deshmukh, et al. · Clinical Cancer Research
Abstract PD9-04: Context-dependent tumor suppressor role of RHOA in breast cancer through cooperation with CDH1 loss
2026 · H. Dopeso, L. Ferrando, et al. · Clinical Cancer Research
Abstract PS1-10-16: Longitudinal genomic profiling of circulating tumor DNA in metastatic invasive lobular (ILC) and no special type (NST) breast cancer
2026 · D. Liu, R. Kumar, et al. · Clinical Cancer Research
Abstract PS2-09-16: Optical genome mapping and multi-modal characterization of breast tumor and organoid samples reveal structural variation and gene fusion signatures
2026 · R. Kumar, O. Shah, et al. · Clinical Cancer Research
Abstract PS2-09-04: Predicting outcomes for patients with mixed ductal/lobular carcinoma of the breast based on circulating tumor DNA positivity patterns
2026 · J. Foldi, S. Satta, et al. · Clinical Cancer Research
Abstract PS2-08-12: Age-associated divergence in breast cancer: clinical, molecular, and genomic insights from a large real-world cohort
2026 · J. Foldi, S. Satta, et al. · Clinical Cancer Research
Works count: 8
Citation count:
H-index:
I10-index:
Year
Topic
Type